BACH1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.993400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.593800E-01
Normal-vs-Stage2
8.931800E-01
Normal-vs-Stage3
5.896400E-01
Normal-vs-Stage4
5.588600E-01
Stage1-vs-Stage2
4.350400E-01
Stage1-vs-Stage3
8.523200E-01
Stage1-vs-Stage4
2.255800E-01
Stage2-vs-Stage3
4.188400E-01
Stage2-vs-Stage4
5.292400E-01
Stage3-vs-Stage4
3.106400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.479200E-01
Normal-vs-AfricanAmerican
5.436000E-01
Normal-vs-Asian
7.682800E-01
Caucasian-vs-AfricanAmerican
1.970840E-01
Caucasian-vs-Asian
6.814000E-01
AfricanAmerican-vs-Asian
2.223600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.714800E-01
Normal-vs-Female
9.594600E-01
Male-vs-Female
7.421800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.905600E-01
Normal-vs-Age(41-60Yrs)
5.793600E-01
Normal-vs-Age(61-80Yrs)
7.751200E-01
Normal-vs-Age(81-100Yrs)
7.458200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.957600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.667800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.002000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.184500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.181020E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.440800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.187800E-01
Normal-vs-Daily Drinker
6.509200E-01
Normal-vs-Weekly Drinker
5.975400E-01
Normal-vs-Occasional Drinker
8.800800E-01
Normal-vs-Social Drinker
9.991600E-01
Non Drinker-vs-Daily Drinker
3.595600E-01
Non Drinker-vs-Weekly Drinker
5.176600E-01
Non Drinker-vs-Occasional Drinker
5.970800E-01
Non Drinker-vs-Social Drinker
8.625800E-01
Daily Drinker-vs-Weekly Drinker
7.710600E-01
Daily Drinker-vs-Occasional Drinker
2.561200E-01
Daily Drinker-vs-Social Drinker
4.104000E-01
Weekly Drinker-vs-Occasional Drinker
3.404600E-01
Weekly Drinker-vs-Social Drinker
5.109200E-01
Occasional Drinker-vs-Social Drinker
7.916200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.042400E-01
Normal-vs-Grade 2
5.360300E-02
Normal-vs-Grade 3
5.150200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.600200E-03
Grade 1-vs-Grade 3
2.864900E-03
Grade 1-vs-Grade 4
3.042400E-01
Grade 2-vs-Grade 3
1.973750E-01
Grade 2-vs-Grade 4
5.360300E-02
Grade 3-vs-Grade 4
5.150200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.337800E-01
Normal-vs-NonDiabetic
8.880800E-01
Diabetic-vs-NonDiabetic
8.490800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.225600E-01
Normal-vs-NoPancreatitis
9.250000E-01
Pancreatitis-vs-NoPancreatitis
8.695800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.978000E-01
Normal-vs-N1
8.797800E-01
N0-vs-N1
1.477990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.901600E-01
Normal-vs-TP53-NonMutant
4.609200E-01
TP53-Mutant-vs-TP53-NonMutant
6.444500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
